Notification of Shareholding
2008年2月29日 - 6:14PM
RNSを含む英国規制内ニュース (英語)
RNS Number:0378P
Arana Therapeutics Limited
29 February 2008
For Immediate Release 29 February 2008
Arana Therapeutics Limited
Notification of Shareholding
Arana Therapeutics Limited, (AIM: AAHx ASX: AAH) (the "Company"), the Australian
biopharmaceutical company that uses superior technology to develop next
generation drugs that will improve the lives of patients with inflammatory
diseases and cancer advises that on 26 February 2008 Lim Sen Yap has advised the
Australian Securities Exchange (www.asx.com.au) that himself and his associates
(as defined under the Corporations Act 2001 (Australia)) held a total of
24,984,089 ordinary shares of the Company (10.63% of the issued share capital of
the Company). A copy of the notice filed by Lim Sen Yap is attached.
For further information, please contact:
Arana Therapeutics Limited
Dr John Chiplin, Chief Executive Officer +61 (0)2 8061 9900
Niall Henderson, Chief Financial Officer +61 (0)2 8061 9900
Buchanan Communication
Lisa Baderoon/Rebecca Skye Dietrich +44 (0)20 7466 5000
Nomura Code Securities
Charles Walker +44 (0)20 7776 1206
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLGCGDDXBDGGIC
Arana Therap. (LSE:AAHX)
過去 株価チャート
から 5 2024 まで 6 2024
Arana Therap. (LSE:AAHX)
過去 株価チャート
から 6 2023 まで 6 2024
Real-Time news about Arana Therap. (ロンドン証券取引所): 0 recent articles
その他のArana Therapeuticsニュース記事